Status:
RECRUITING
Photobiomodulation in Dry Age Related Macular Degeneration
Lead Sponsor:
Azienda Ospedaliera Universitaria Mater Domini, Catanzaro
Conditions:
Age-Related Macular Degeneration
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to evaluate effects of consecutive Yellow and Red Light Emitting Diode photobiomodulation in dry age-related macular degeneration (AMD). The main questions it aims t...
Eligibility Criteria
Inclusion
- BCVA ETDRS \> 40 L ETDRS at 4 meters
- Diagnosis of DRY AMD AREDS grade 2-3
- Ability to communicate well with the investigator and able to understand and comply with the requirements of the study
Exclusion
- Concomitant epilepsy
- Neurological diseases
- Psychiatric pathologies
- Herpes virus infections
- Dense cataract
- Pregnancy
- Other significant ocular and/or retinal diseases
Key Trial Info
Start Date :
April 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT06046118
Start Date
April 1 2023
End Date
December 31 2024
Last Update
September 19 2024
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Paris
Paris, France
2
Università degli Studi di Ferrara
Ferrara, Italy
3
Università degli studi della Campania Luigi Vanvitelli
Napoli, Italy
4
Università di Torino
Torino, Italy